Background & Aim Expansion of T cells is a crucial step of many cellular immunotherapy protocols, which require large numbers of immune cells to eradicate malignant cells. However, it remains a major translational and commercial bottleneck due to the manual, small scale culturing systems used for their production. One of the main concerns is that primary T cells are shear sensitive and therefore do not grow as effectively in more scalable, agitated systems, such as stirred tank bioreactors, as compared with static conditions. However, the use of stirred culture systems for T cell expansion offers many potential advantages over the static culture systems commonly used today, including homogeneity of culture conditions, ease of sampling, and implementation of control systems. Methods, Results & Conclusion In our study, we explore a robust and practical platform for adoptive cell culture using stirred-tank bioreactor and novel biaxial rotary bioreactor for large-scale and high-quality cellular production. We have investigated various factors, such as bioreactor parameters, media, supplements and stimulation, with a suitable structure of scaling-up the bioreactors with robustness and reproducibility of the process. T cell quality was monitored using surface markers and intracellular cytokines as the critical quality assessment criteria in early, middle and late stages of cell production. Our approach addresses the fundamental scaling challenges in the manufacturing process.